Cargando…
The impact of obesity and dyslipidemia on Remdesivir effectiveness in hospitalized patients with SARS-CoV-2-related pneumonia: An observational study
BACKGROUND AND AIMS: Remdesivir (GS-5734), an inhibitor of the viral RNA-dependent, RNA polymerase was early identified as a promising therapeutic candidate against COVID-19. Our aim was to evaluate the impact of several metabolic parameters on Remdesivir effectiveness among hospitalized COVID-19 pa...
Autores principales: | Tumminia, Andrea, Romano, Raffaella, Brugaletta, Giuseppe, Scicali, Roberto, Biondi, Giuseppina, Oliveri, Rosario, Romano, Marcello, San Lio, Paola Magnano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994684/ https://www.ncbi.nlm.nih.gov/pubmed/35508458 http://dx.doi.org/10.1016/j.numecd.2022.04.005 |
Ejemplares similares
-
Early Stage Combination Treatment with Methylprednisolone Pulse and Remdesivir for Severe COVID-19 Pneumonia
por: Mastruzzo, Claudio, et al.
Publicado: (2023) -
Internal iliac artery aneurysm embolization with direct percutaneous puncture and thrombin injection
por: Giordano, Giuseppe, et al.
Publicado: (2019) -
Early experience with remdesivir in SARS-CoV-2 pneumonia
por: Durante-Mangoni, Emanuele, et al.
Publicado: (2020) -
Remdesivir in a pregnant patient with COVID-19 pneumonia
por: Dande, Ranadheer, et al.
Publicado: (2021) -
Remdesivir in Solid Organ Recipients for COVID-19 Pneumonia
por: Fesu, Dorottya, et al.
Publicado: (2022)